An example of anti-BCL-2 precise treatment is the drug venetoclax since it blocks the mitochondrial anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein, leading to programmed cell death of CLL cells or small lymphocytic lymphoma (SLL) [79,80]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.